35Pharma

Active#49 in Canada

Activin inhibitors

Biotech›activin inhibitors

Founded2017

HQMontreal

Raisednot disclosed

Last roundSeries C · Jul 2025

Country of originCanadaListed in the Canada ranking

Where would you invest?CanadaJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Canada · all sectors	Top 50	#49	Edition 0 – beta · October 2026	9 Oct 2026

Rank historyOct 2026 · #49First edition: no movements yet.

Estimated valuation

AI · Canada ranking

≈ USD 360MUSD 180–720M · Hundreds of M$ Low confidence

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Published valuation: USD 360M · Jul 2025
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

not disclosed raised in total

Date	Round	Amount	Type	Investors
Jul 2025	Series C	amount undisclosed	—	—

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of 35Pharma as a PDF, on one of three angles only:

ValuationWhat is 35Pharma worth?

Versus competitorsIs #49 the right rank?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back 35Pharma whether or not it has agreed: your intention joins the pool on 35Pharma, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back 35Pharma Or back biotech in Canada

Pool on 35PharmaBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run 35Pharma?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Canada

Full Canada ranking →

Borealis Biosciences#26Biotech › RNA therapies for kidney diseaseHundreds of M$Aspect Biosystems#33Biotech › bioprinted tissue therapiesHundreds of M$Abdera Therapeutics#35Biotech › antibody radiopharmaceuticalsHundreds of M$Clearco#48Fintech › revenue-based financing for online sellersHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.